Adult liver transplantation in the USA

Current Opinion in Gastroenterology

Volumn 27, Issue 3, 2011, Pages 240-247

  Alqahtani, Saleh A ^a   Larson, Anne M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

cirrhosis; hepatocellular carcinoma; indications; liver transplantation; outcomes

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE LIVER FAILURE; ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; BRAIN INJURY; CHRONIC KIDNEY DISEASE; CHRONIC LIVER DISEASE; CHRONIC LIVER FAILURE; CORONARY ARTERY DISEASE; HEMANGIOENDOTHELIOMA; HEPATOBLASTOMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; NONALCOHOLIC FATTY LIVER; PRIMARY SCLEROSING CHOLANGITIS; SEPSIS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; UNITED STATES; VIRUS HEPATITIS; WILSON DISEASE;

EID: 85027955898     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e3283457d5d     Document Type: Article

References (72)

1. Kim WR. The burden of hepatitis C in the United States. Hepatology 2002; 36:S30-S34. (Pubitemid 35253461)
2. Collins BH, Pirsch JD, Becker YT, et al. Long-term results of liver transplantation in older patients 60 years of age and older. Transplantation 2000; 70:780-783.
3. Larson AM, Curtis JR. Integrating palliative care for liver transplant candidates: 'too well for transplant, too sick for life'. JAMA 2006; 295:2168-2176.
4. Brown RS Jr, Lake JR. The survival impact of liver transplantation in the MELD era, and the future for organ allocation and distribution. Am J Transplant 2005; 5:203-204. (Pubitemid 40179505)
5. -2009 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1999-2008. U.S. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation. 2010.
6. Starzl TE, Marchioro TL, Vonkaulla KN, et al. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963; 117:659-676.
7. Starzl TE, Groth CG, Brettschneider L, et al. Orthotopic homotransplantation of the human liver. Ann Surg 1968; 168:392-415.
8. Starzl TE, Ishikawa M, Putnam CW, et al. Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc 1974; 6:129-139.
9. National Institutes of Health Consensus Development Conference Statement: liver transplantation, 20-23 June 1983. Hepatology 1984; 4:107S-110S.
10. National Institutes of Health Consensus Development Conference on Liver Transplantation. Sponsored by the National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases and the National Institutes of Health Office of Medical Applications of Research. Hepatology 1984; 4:1S-110S.
11. Grossman EJ, Millis JM. Liver transplantation for nonhepatocellular carcinoma malignancy: indications, limitations, and analysis of the current literature. Liver Transpl 2010; 16:930-942.
12. Bergstralh EJ, Monico CG, Lieske JC, et al. Transplantation outcomes in primary hyperoxaluria. Am J Transplant 2010; 10:2493-2501.
13. Nudo CG, Yoshida EM, Bain VG, et al. Liver transplantation for hepatic epithelioid hemangioendothelioma: the Canadian multicentre experience. Can J Gastroenterol 2008; 22:821-824.
14. Gores GJ, Heimbach JK, Rosen CB. Liver transplantation for nonhepatocellular carcinoma malignancies. Liver Transpl 2010; 16:S22-S25.
15. Bower WA, Johns M, Margolis HS, et al. Population-based surveillance for acute liver failure. Am J Gastroenterol 2007; 102:2459-2463. (Pubitemid 47631759)
16. Ritt DJ, Whelan G, Werner DJ, et al. Acute hepatic necrosis with stupor or coma. An analysis of thirty-one patients. Medicine (Baltimore) 1969; 48:151-172.
17. Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005; 42:1364-1372. (Pubitemid 43260039)
18. Larson AM. Diagnosis and management of acute liver failure. Curr Opin Gastroenterol 2010; 26:214-221.
19. Ostapowicz G, Lee WM. Acute hepatic failure: a Western perspective. J Gastroenterol Hepatol 2000; 15:480-488. (Pubitemid 30327048)
20. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137:947-954. (Pubitemid 35440240)
21. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693-699. (Pubitemid 26079803)
22. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33:1394-1403. (Pubitemid 32496976)
23. Rosen CB, Heimbach JK, Gores GJ. Liver transplantation for cholangiocarcinoma. Transpl Int 2010; 23:692-697.
24. Alqahtani S, Watt KD. Liver transplantation: indications and patient selection. In: Talley HJ, Lindor KD, Vargas HE, editors. Practical gastroenterology and hepatology: liver and biliary disease. Hoboken, NJ: Wiley-Blackwell; 2010. pp. 297-304.
25. Herrero JI, Lorenzo M, Quiroga J, et al. De novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival. Liver Transpl 2005; 11:89-97. (Pubitemid 40124447)
26. Murray KF, Carithers RL Jr. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology 2005; 41:1407-1432. (Pubitemid 40770295)
27. Ahmed A, Keeffe EB. Current indications and contraindications for liver transplantation. Clin Liver Dis 2007; 11:227-247. (Pubitemid 46990959)
28. Coffin CS, Stock PG, Dove LM, et al. Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients. Am J Transplant 2010; 10:1268-1275.
29. Subramanian A, Sulkowski M, Barin B, et al. MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterology 2010; 138:159-164.
30. Hirschfield GM, Gibbs P, Griffiths WJ. Adult liver transplantation: what nonspecialists need to know? BMJ 2009; 338:1321-1327.
31. Alqahtani SA, Fouad TR, Lee SS. Cirrhotic cardiomyopathy. Semin Liver Dis 2008; 28:59-69. (Pubitemid 351326533)
32. Fili D, Vizzini G, Biondo D, et al. Clinical burden of screening asymptomatic patients for coronary artery disease prior to liver transplantation. Am J Transplant 2009; 9:1151-1157.
33. Carey WD, Dumot JA, Pimentel RR, et al. The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation 1995; 59:859-864.
34. Safadi A, Homsi M, Maskoun W, et al. Perioperative risk predictors of cardiac outcomes in patients undergoing liver transplantation surgery. Circulation 2009; 120:1189-1194.
35. Ehtisham J, Altieri M, Salame E, et al. Coronary artery disease in orthotopic liver transplantation: pretransplant assessment and management. Liver Transpl 2010; 16:550-557.
36. Appleton CP, Hurst RT, Lee KS, et al. Long-term cardiovascular risk in the orthotopic liver transplant population. Liver Transpl 2006; 12:352-355.
37. Davidson CJ, Gheorghiade M, Flaherty JD, et al. Predictive value of stress myocardial perfusion imaging in liver transplant candidates. Am J Cardiol 2002; 89:359-360. (Pubitemid 34113805)
38. Kryzhanovski VA, Beller GA. Usefulness of preoperative noninvasive radionuclide testing for detecting coronary artery disease in candidates for liver transplantation. Am J Cardiol 1997; 79:986-988. (Pubitemid 27197942)
39. Dawwas MF, Gimson AE. Candidate selection and organ allocation in liver transplantation. Semin Liver Dis 2009; 29:40-52.
40. Merion RM, Schaubel DE, Dykstra DM, et al. The survival benefit of liver transplantation. Am J Transplant 2005; 5:307-313. (Pubitemid 40179517)
41. Gallegos-Orozco JF, Vargas HE. Liver transplantation: from child to MELD. Med Clin North Am 2009; 93:931-950; ix.
42. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464-470. (Pubitemid 32119037)
43. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864-871. (Pubitemid 30169932)
44. Said A, Williams J, Holden J, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004; 40:897-903. (Pubitemid 38670122)
45. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124:91-96. (Pubitemid 36055342)
46. Wiesner RH, McDiarmid SV, Kamath PS, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001; 7:567-580. (Pubitemid 32677880)
47. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology 2007; 45:797-805. (Pubitemid 46450631)
48. Biggins SW, Bambha K. MELD-based liver allocation: who is underserved? Semin Liver Dis 2006; 26:211-220. (Pubitemid 44141928)
49. Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006; 130:1652-1660. (Pubitemid 43668830)
50. Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359:1018-1026.
51. Myers RP, Shaheen AA, Aspinall AI, et al. Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate. J Hepatol 2011; 54:462-470.
52. Myers RP, Shaheen AA, Faris PD, Burak KW. Modification of MELD and MELDNa to include serum albumin improves prediction of mortality on the liver transplant waiting list [abstract]. Hepatology 2010; 52:375A.
53. Vitale A, Volk ML, Pastorelli D, et al. Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety. Hepatology 2010; 51:165-173.
54. Cucchetti A, Vitale A, Gaudio MD, et al. Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. Am J Transplant 2010; 10:619-627.
55. Bloom RD, Bleicher M. Simultaneous liver-kidney transplantation in the MELD era. Adv Chronic Kidney Dis 2009; 16:268-277.
56. Levine MH, Parekh J, Feng S, Freise C. Kidney transplant performed after liver transplant: a single center experience. Clin Transplant 2010. [Epub ahead of print]
57. Groth CG. Forty years of liver transplantation: personal recollections. Transplant Proc 2008; 40:1127-1129. (Pubitemid 351794284)
58. Forman LM, Lewis JD, Berlin JA, et al. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122:889-896. (Pubitemid 34267271)
59. Narang TK, Ahrens W, Russo MW. Postliver transplant cholestatic hepatitis C: a systematic review of clinical and pathological findings and application of consensus criteria. Liver Transpl 2010; 16:1228-1235.
60. Roche B, Samuel S. Hepatitis C virus: up to the minute. Liver Transpl 2010; 16:S26-S35.
61. Gallegos-Orozco JF, Yosephy A, Noble B, et al. Natural history of postliver transplantation hepatitis C: a review of factors that may influence its course. Liver Transpl 2009; 15:1872-1881.
62. Cross TJ, Calvaruso V, Foxton MR, et al. A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis C recurrence after liver transplantation. J Viral Hepat 2010; 17:640-649.
63. Lucey MR. Liver transplantation for alcoholic liver disease. Clin Liver Dis 2007; 11:283-289. (Pubitemid 46990960)
64. Vanlemmens C, Di Martino V, Milan C, et al. Immediate listing for liver transplantation versus standard care for Child-Pugh stage B alcoholic cirrhosis: a randomized trial. Ann Intern Med 2009; 150:153-161.
65. Bellamy CO, Di Martini AM, Ruppert K, et al. Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation 2001; 72:619-626. (Pubitemid 32802742)
66. Kuo HT, Sampaio MS, Ye X, et al. Risk factors for new-onset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing database. Transplantation 2010; 89:1134-1140.
67. Watt KD. Obesity and metabolic complications of liver transplantation. Liver Transpl 2010; 16:S65-S71.
68. Sharma P, Welch K, Eikstadt R, et al. Renal outcomes after liver transplantation in the model for end-stage liver disease era. Liver Transpl 2009; 15:1142-1148.
69. Di Benedetto F, Di Sandro S, De Ruvo N, et al. First report on a series of HIV patients undergoing rapamycin monotherapy after liver transplantation. Transplantation 2010; 89:733-738.
70. Jain A, Reyes J, Kashyap R, et al. Long-term survival after liver transplantation in 4000 consecutive patients at a single center. Ann Surg 2000; 232:490-500.
71. Mells G, Neuberger J. Long-term care of the liver allograft recipient. Semin Liver Dis 2009; 29:102-120.
72. Evans RW. Liver transplants and the decline in deaths from liver disease. Am J Public Health 1997; 87:868-869.